Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB26FE0SN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,846
Award facts
- Contract value 100% obligated
- $1,845.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $1,845.83. This is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, issued as a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio of federal awards encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eczema, asthma, and other allergic conditions, making this delivery order consistent with the company's role in supplying specialized healthcare commodities to support Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FE0SN?
SPE2DB26FE0SN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FE0SN worth?
The government has obligated $1,846 on SPE2DB26FE0SN.
Is contract SPE2DB26FE0SN an order under another contract?
Yes. SPE2DB26FE0SN is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB26FE0SN competed?
The extent of competition for SPE2DB26FE0SN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award